De Rita Fabrizio, Hasan Asif, Haynes Simon, Crossland David, Kirk Richard, Ferguson Lee, Peng Edward, Griselli Massimo
Department of Paediatric Cardiac Surgery, Freeman Hospital, Newcastle Upon Tyne, UK
Department of Paediatric Cardiac Surgery, Freeman Hospital, Newcastle Upon Tyne, UK.
Eur J Cardiothorac Surg. 2014 Oct;46(4):656-62; discussion 662. doi: 10.1093/ejcts/ezu039. Epub 2014 Feb 26.
A significant number of children affected by congenital heart disease (CHD) develop heart failure early or late after surgery, and heart transplantation (OHTx) remains the last treatment option. Due to shortage of donor organs in paediatric group, mechanical circulatory support (MCS) is now routinely applied as bridging strategy to increase survival on the waiting list for OTHx. We sought to assess the impact of MCS as intention to bridge to OHTx in patients with CHD less than 16 years of age.
From 1998 to 2013, 106 patients received 113 episodes of MCS with paracorporeal devices as intention to bridge to OHTx. Twenty-nine had CHD, 15 (52%) with two-ventricle (Group A) and 14 (48%) with single-ventricle physiology (Group B). In Group A, 5 children had venoarterial extracorporeal membrane oxygenation (VA ECMO), 6 left ventricular assist device (LVAD), 2 biventricular assist device (BIVAD), 1 VA ECMO followed by BIVAD and 1 BIVAD followed by VA ECMO. In Group B, VA ECMO was used in 7 children, univentricular assist device (UVAD) changed to VA ECMO in 4, UVAD in 2 and surgical conversion to two-ventricles physiology with BIVAD support changed to VA ECMO in 1.
Twenty-one of 29 (72%) children survived to recovery/OHTx. Seven of 29 (59%) survived to discharge. In Group A, 11/15 (73%) survived to recovery/OHTx and 9/15 (60%) survived to discharge. Four of 15 (27%) died awaiting OHTx. One child had graft failure requiring VA ECMO and was bridged successfully to retransplantation. One child dying after OHTx had acute rejection, was supported with VA ECMO and then BIVAD but did not recover. One patient had an unsuccessful second run on BIVAD 1 year after recovery from VA ECMO. In Group B, 10/14 (71%) survived to recovery/OHTx and 8/14 (57%) survived to discharge. Four of 14 (29%) died awaiting OHTx. Of deaths after OHTx, 1 occurred intraoperatively and 1 was consequent to graft failure and had an unsuccessful second run with VA ECMO.
Children with CHD can be successfully bridged with MCS to heart transplantation. Single-ventricle circulation compared with biventricular physiology does not increase the risk of death before transplant or before hospital discharge.
大量先天性心脏病(CHD)患儿在手术后早期或晚期会发生心力衰竭,心脏移植(OHTx)仍是最后的治疗选择。由于儿科供体器官短缺,机械循环支持(MCS)现在通常作为一种过渡策略应用,以提高在等待OHTx名单上的生存率。我们试图评估MCS作为小于16岁CHD患者过渡到OHTx的意向性治疗的影响。
1998年至2013年,106例患者接受了113次使用体外装置的MCS治疗,作为过渡到OHTx的意向性治疗。29例患有CHD,15例(52%)为双心室(A组),14例(48%)为单心室生理状态(B组)。在A组中,5例儿童使用静脉-动脉体外膜肺氧合(VA ECMO),6例使用左心室辅助装置(LVAD),2例使用双心室辅助装置(BIVAD),1例先使用VA ECMO后使用BIVAD,1例先使用BIVAD后使用VA ECMO。在B组中,7例儿童使用VA ECMO,4例将单心室辅助装置(UVAD)改为VA ECMO,2例使用UVAD,1例手术转换为双心室生理状态并使用BIVAD支持后改为VA ECMO。
29例患儿中有21例(72%)存活至康复/OHTx。29例中有7例(59%)存活至出院。在A组中,15例中有11例(73%)存活至康复/OHTx,15例中有9例(60%)存活至出院。15例中有4例(27%)在等待OHTx时死亡。1例患儿发生移植失败,需要VA ECMO,并成功过渡到再次移植。1例患儿在OHTx后死亡,发生急性排斥反应,先使用VA ECMO然后使用BIVAD支持,但未康复。1例患者在从VA ECMO康复1年后第二次使用BIVAD失败。在B组中,14例中有10例(71%)存活至康复/OHTx,14例中有8例(57%)存活至出院。14例中有4例(29%)在等待OHTx时死亡。在OHTx后的死亡病例中,1例发生在术中,1例因移植失败,第二次使用VA ECMO失败。
CHD患儿可以通过MCS成功过渡到心脏移植。与双心室生理状态相比,单心室循环不会增加移植前或出院前的死亡风险。